177 related articles for article (PubMed ID: 28716650)
1. The Use of Prostate Specific Antigen Screening in Purchased versus Direct Care Settings: Data from the TRICARE® Military Database.
Cole AP; Jiang W; Lipsitz SR; Learn PA; Sun M; Choueiri TK; Nguyen PL; Kibel AS; Menon M; Sammon JD; Koehlmoos T; Haider A; Trinh QD
J Urol; 2017 Dec; 198(6):1295-1300. PubMed ID: 28716650
[TBL] [Abstract][Full Text] [Related]
2. Intrapartum obstetric care in the United States military: Comparison of military and civilian care systems within TRICARE.
Ranjit A; Jiang W; Zhan T; Kimsey L; Staat B; Witkop CT; Little SE; Haider AH; Robinson JN
Birth; 2017 Dec; 44(4):337-344. PubMed ID: 28833512
[TBL] [Abstract][Full Text] [Related]
3. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
Zanwar P; Lin YL; Kuo YF; Goodwin JS
BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
5. Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare.
Bynum J; Song Y; Fisher E
J Am Geriatr Soc; 2010 Apr; 58(4):674-80. PubMed ID: 20345867
[TBL] [Abstract][Full Text] [Related]
6. Purchased Behavioral Health Care Received by Military Health System Beneficiaries in Civilian Medical Facilities, 2000-2014.
Wooten NR; Brittingham JA; Pitner RO; Tavakoli AS; Jeffery DD; Haddock KS
Mil Med; 2018 Jul; 183(7-8):e278-e290. PubMed ID: 29420772
[TBL] [Abstract][Full Text] [Related]
7. Contemporary National Trends of Prostate Cancer Screening Among Privately Insured Men in the United States.
Kim SP; Karnes RJ; Gross CP; Meropol NJ; Van Houten H; Abouassaly R; Shah ND
Urology; 2016 Nov; 97():111-117. PubMed ID: 27527411
[TBL] [Abstract][Full Text] [Related]
8. Is There Variation in Procedural Utilization for Lumbar Spine Disorders Between a Fee-for-Service and Salaried Healthcare System?
Schoenfeld AJ; Makanji H; Jiang W; Koehlmoos T; Bono CM; Haider AH
Clin Orthop Relat Res; 2017 Dec; 475(12):2838-2844. PubMed ID: 28074438
[TBL] [Abstract][Full Text] [Related]
9. Lessons from Medicare coverage of colonoscopy and prostate-specific antigen test.
Xu WY; Dowd B
Med Care Res Rev; 2015 Feb; 72(1):3-24. PubMed ID: 25552266
[TBL] [Abstract][Full Text] [Related]
10. Exnovation of Low Value Care: A Decade of Prostate-Specific Antigen Screening Practices.
Bynum J; Passow H; Carmichael D; Skinner J
J Am Geriatr Soc; 2019 Jan; 67(1):29-36. PubMed ID: 30291742
[TBL] [Abstract][Full Text] [Related]
11. Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.
Shoag J; Halpern JA; Lee DJ; Mittal S; Ballman KV; Barbieri CE; Hu JC
J Urol; 2016 Oct; 196(4):1047-52. PubMed ID: 27060052
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing use of the prostate-specific antigen screening test in primary care.
Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL.
Fujizuka Y; Ito K; Oki R; Suzuki R; Sekine Y; Koike H; Matsui H; Shibata Y; Suzuki K
Int J Urol; 2017 Aug; 24(8):602-609. PubMed ID: 28560739
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Screening in Early Medicaid Expansion States.
Sammon JD; Serrell EC; Karabon P; Leow JJ; Abdollah F; Weissman JS; Han PKJ; Hansen M; Menon M; Trinh QD
J Urol; 2018 Jan; 199(1):81-88. PubMed ID: 28765069
[TBL] [Abstract][Full Text] [Related]
15. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
[TBL] [Abstract][Full Text] [Related]
16. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
Drazer MW; Huo D; Eggener SE
J Clin Oncol; 2015 Aug; 33(22):2416-23. PubMed ID: 26056181
[TBL] [Abstract][Full Text] [Related]
17. Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population.
Raffin E; Onega T; Bynum J; Austin A; Carmichael D; Bronner K; Goodney P; Hyams ES
Cancer Epidemiol; 2017 Oct; 50(Pt A):68-75. PubMed ID: 28822325
[TBL] [Abstract][Full Text] [Related]
18. Examination of prostate-specific antigen (PSA) screening in military and civilian men: analysis of the 2018 behavioral risk factor surveillance system.
Hoffman SS; Smith AW; Kent EE; Doria-Rose VP; Kobrin SC; Mollica MA
Cancer Causes Control; 2022 Mar; 33(3):393-402. PubMed ID: 35034262
[TBL] [Abstract][Full Text] [Related]
19. Prescriptions of Psychotropic Medications by Providers Treating Children of Military Service Members.
Kucera A; Koehlmoos T; Grunwald L; Banaag A; Schvey NA; Quinlan J; Tanofsky-Kraff M
Mil Med; 2023 Mar; 188(3-4):615-620. PubMed ID: 35257165
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
Black A; Berg CD
Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
